Australian researchers for global tech company IBM have applied machine learning to identify proteins in blood that can predict Alzheimer’s disease risk.
Australian company Actinogen Medical is developing a new drug — Xanamem — that blocks the excess production of stress hormone cortisol in Alzheimer’s sufferers, offering a potential treatment for the disease.
"There's an app for that" is a cliche, and the phrase "ageing population" often turns up in political discourse. But even if there's a person with dementia in your family, would you have thought of an app that can make their home more accessible for them?
WE NEED NBN 2.0 ~ GUESS WHAT THIS WILL BE... HINT ~ FTTH....
I abandoned the FTTN nbn for 5G (well actually 4G originally but its been upgraded) and I wont be going[…]
Surely this would make Apple a reseller and therefore exposed to all of the rules and conditions that other resellers[…]
Will licenses be allocated Australia wide, as was the case with 700/2600MHz auctions, or based on regional areas as per[…]
Could I point out with all due respect to James Perkins that NBN Co is an independent statutory organisation and,[…]